Folotyn for Non-Hodgkin's Lymphoma Olean NY

The drug Folotyn (pralatrexate) has been approved to treat Peripheral T-cell Lymphoma (PTCL), an often aggressive form of non-Hodgkin's lymphoma, the U.S. Food and Drug Administration said Friday. The drug, given accelerated approval because it treats an unmet medical need, was sanctioned for people whose disease has returned or hasn't responded to other types of chemotherapy, the agency said in a news release.

Local Companies

Neeta Soni
(716) 372-1046
328 W Delaware Ave
Olean, NY
EDWARD JORDAN, MD
(716) 372-7600
516 Main Street
Olean, NY
Narayan Pundarik Nayak, MD
814-362-8390
195 Pleasant St Unit 3
Bradford, PA
Edward Francis Jordan, MD
716-372-7600
516 Main St
Olean, NY
Neeta Son, MD
716-372-1046
602 Wayne St
Olean, NY
Edward F Jordan
(716) 372-7600
516 Main St
Olean, NY
Yahya Fadl
(814) 368-3123
116 Interstate Pkwy
Bradford, PA
EYAD AL-HATTAB, MD
(814) 362-8425
116 Interstate Parkway
Bradford, PA
Michael John Pelechaty, MD
515 Main St
Olean, NY
Srinivas P Thandla, MD
716-945-0368
4039 Route 219 103
Allegany, NY
Data Provided by:
    

Provided By:

FRIDAY, Sept. 25 (HealthDay News) -- The drug Folotyn (pralatrexate) has been approved to treat Peripheral T-cell Lymphoma (PTCL), an often aggressive form of non-Hodgkin's lymphoma, the U.S. Food and Drug Administration said Friday.

The drug, given accelerated approval because it treats an unmet medical need, was sanctioned for people whose disease has returned or hasn't responded to other types of chemotherapy, the agency said in a news release.

PTCL strikes fewer than 9,500 people each year in the United States, the FDA said. The disease affects a type of white blood cell, called a T-cell, involved in the body's disease-fighting immune system.

Approval of Folotyn was based on clinical data showing it reduced tumor size in 27 percent of 109 people with PTCL who were studied. The most common adverse reactions included sores of the lips, mouth and digestive tract, low white blood cell counts, fever, nausea and fatigue.

Since the drug can harm a fetus, women taking Folotyn should avoid becoming pregnant, the FDA said. Anyone taking the drug should also take folate and vitamin B12 supplements to help reduce irritation of the mucous membranes.

Folotyn is produced by Colorado-based Allos Therapeutics, which is required to conduct additional studies of tumor shrinkage and life expectancy, the agency said.

More information

The FDA has more about this drug.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Donor Stem-Cell Transplant for Acute Myeloid Leukemia Olean NY
For most patients with acute myeloid leukemia (AML) who come out of remission, donor stem cells appear to offer the best shot at survival, a new analysis shows.
- Green Tea and Hematologic Malignancies Olean NY